A review of the molecular design and biological activities of RXR agonists

Nathalia Rodrigues de Almeida, Martin Conda-Sheridan

Research output: Contribution to journalReview article

Abstract

An attractive approach to combat disease is to target theregulation of cell function. At the heart of this task are nuclear receptors (NRs); which control functions such as gene transcription. Arguably, the key player in this regulatory machinery is the retinoid X receptor (RXR). This NR associates with a third of the NRs found in humans. Scientists have hypothesized that controlling the activity of RXR is an attractive approach to control cellular functions that modulate diseases such as cancer, diabetes, Alzheimer's disease and Parkinson's disease. In this review, we will describe the key features of the RXR, present a historic perspective of the first RXR agonists, and discuss various templates that have been reported to activate RXR with a focus on their molecular structure, biological activity, and limitations. Finally, we will present an outlook of the field and future directions and considerations to synthesize or modulate RXR agonists to make these compounds a clinical reality.

Original languageEnglish (US)
Pages (from-to)1372-1397
Number of pages26
JournalMedicinal Research Reviews
Volume39
Issue number4
DOIs
StatePublished - Jul 2019

Fingerprint

Retinoid X Receptors
Cytoplasmic and Nuclear Receptors
Molecular Structure
Parkinson Disease
Alzheimer Disease
Genes
Neoplasms

Keywords

  • 9-cis-retinoic acid
  • anticancer agent
  • bexarotene
  • retinoid X receptor
  • rexinoids

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Cite this

A review of the molecular design and biological activities of RXR agonists. / de Almeida, Nathalia Rodrigues; Conda-Sheridan, Martin.

In: Medicinal Research Reviews, Vol. 39, No. 4, 07.2019, p. 1372-1397.

Research output: Contribution to journalReview article

@article{84fd981e19e7459daa57a6370f9c7085,
title = "A review of the molecular design and biological activities of RXR agonists",
abstract = "An attractive approach to combat disease is to target theregulation of cell function. At the heart of this task are nuclear receptors (NRs); which control functions such as gene transcription. Arguably, the key player in this regulatory machinery is the retinoid X receptor (RXR). This NR associates with a third of the NRs found in humans. Scientists have hypothesized that controlling the activity of RXR is an attractive approach to control cellular functions that modulate diseases such as cancer, diabetes, Alzheimer's disease and Parkinson's disease. In this review, we will describe the key features of the RXR, present a historic perspective of the first RXR agonists, and discuss various templates that have been reported to activate RXR with a focus on their molecular structure, biological activity, and limitations. Finally, we will present an outlook of the field and future directions and considerations to synthesize or modulate RXR agonists to make these compounds a clinical reality.",
keywords = "9-cis-retinoic acid, anticancer agent, bexarotene, retinoid X receptor, rexinoids",
author = "{de Almeida}, {Nathalia Rodrigues} and Martin Conda-Sheridan",
year = "2019",
month = "7",
doi = "10.1002/med.21578",
language = "English (US)",
volume = "39",
pages = "1372--1397",
journal = "Medicinal Research Reviews",
issn = "0198-6325",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - A review of the molecular design and biological activities of RXR agonists

AU - de Almeida, Nathalia Rodrigues

AU - Conda-Sheridan, Martin

PY - 2019/7

Y1 - 2019/7

N2 - An attractive approach to combat disease is to target theregulation of cell function. At the heart of this task are nuclear receptors (NRs); which control functions such as gene transcription. Arguably, the key player in this regulatory machinery is the retinoid X receptor (RXR). This NR associates with a third of the NRs found in humans. Scientists have hypothesized that controlling the activity of RXR is an attractive approach to control cellular functions that modulate diseases such as cancer, diabetes, Alzheimer's disease and Parkinson's disease. In this review, we will describe the key features of the RXR, present a historic perspective of the first RXR agonists, and discuss various templates that have been reported to activate RXR with a focus on their molecular structure, biological activity, and limitations. Finally, we will present an outlook of the field and future directions and considerations to synthesize or modulate RXR agonists to make these compounds a clinical reality.

AB - An attractive approach to combat disease is to target theregulation of cell function. At the heart of this task are nuclear receptors (NRs); which control functions such as gene transcription. Arguably, the key player in this regulatory machinery is the retinoid X receptor (RXR). This NR associates with a third of the NRs found in humans. Scientists have hypothesized that controlling the activity of RXR is an attractive approach to control cellular functions that modulate diseases such as cancer, diabetes, Alzheimer's disease and Parkinson's disease. In this review, we will describe the key features of the RXR, present a historic perspective of the first RXR agonists, and discuss various templates that have been reported to activate RXR with a focus on their molecular structure, biological activity, and limitations. Finally, we will present an outlook of the field and future directions and considerations to synthesize or modulate RXR agonists to make these compounds a clinical reality.

KW - 9-cis-retinoic acid

KW - anticancer agent

KW - bexarotene

KW - retinoid X receptor

KW - rexinoids

UR - http://www.scopus.com/inward/record.url?scp=85067291852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067291852&partnerID=8YFLogxK

U2 - 10.1002/med.21578

DO - 10.1002/med.21578

M3 - Review article

C2 - 30941786

AN - SCOPUS:85067291852

VL - 39

SP - 1372

EP - 1397

JO - Medicinal Research Reviews

JF - Medicinal Research Reviews

SN - 0198-6325

IS - 4

ER -